Vietnam Warns Doctors Of Side Effects Of J&J's Antifungal Nizoral
This article was originally published in PharmAsia News
Executive Summary
Vietnam's Drug Administration warned physicians to be aware of antifungal drug Nizoral (ketoconazole) marketed by Janssen-Cilag, a unit of U.S.-based Johnson & Johnson